Nang Kuang Pharmaceutical Co., Ltd.

TWSE:1752 Stock Report

Market Cap: NT$4.4b

Nang Kuang Pharmaceutical Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 1752?
Owner TypeNumber of SharesOwnership Percentage
Institutions1,161,9881.15%
Individual Insiders17,204,10217%
Private Companies33,195,73532.9%
General Public49,427,17548.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 12 shareholders own 51.06% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
19.8%
Zhengzhao Investment Co., Ltd.
20,014,220NT$864.6m0%no data
6.24%
Ben-Sung Chen
6,297,334NT$272.0m0%no data
5.01%
Ben-Chung Chen
5,057,157NT$218.5m0%no data
3.94%
Song-ban Investment Co., Ltd.
3,978,517NT$171.9m0%no data
3.49%
Yu-Bei Wang
3,525,943NT$152.3m0%no data
3.39%
Li Kuang Investment Co., Ltd.
3,425,176NT$148.0m0%no data
2.97%
Cheng Long Investment Co., Ltd.
2,998,952NT$129.6m0%no data
2.75%
Yiguang Investment Co., Ltd.
2,778,870NT$120.0m0%no data
2.26%
Lixian Chen
2,278,668NT$98.4m0%no data
1.07%
Dimensional Fund Advisors LP
1,083,016NT$46.8m0.74%no data
0.078%
American Century Investment Management Inc
79,000NT$3.4m0%no data
0.045%
Chi-Long Lin
45,000NT$1.9m0%no data